U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C25H21F3N2O
Molecular Weight 422.4422
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of MAVATREP

SMILES

CC(C)(O)C1=CC=CC=C1C2=CC3=C(C=C2)N=C(N3)\C=C\C4=CC=C(C=C4)C(F)(F)F

InChI

InChIKey=ORDHXXHTBUZRCN-NTEUORMPSA-N
InChI=1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+

HIDE SMILES / InChI

Molecular Formula C25H21F3N2O
Molecular Weight 422.4422
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description

Mavatrep (JNJ-39439335) is a TRPV1 antagonist. It exerts analgesic potential. Mavatrep demonstrated sustained pharmacodynamic effects (heat pain perception, heat pain latency, capsaicin-induced flare), and an efficacy signal in participants with osteoarthritis

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
4.6 nM [IC50]

PubMed

Patents

Substance Class Chemical
Record UNII
F197218T99
Record Status Validated (UNII)
Record Version